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ess: gunnevi.sundelin@Summary The aim of this study was to evaluate thigh muscle strength and
endurance in patients with COPD compared with healthy controls. Forty-two
patients (26 women; 16 men) with moderate to severe COPD and 53 (29 women; 24
men) age-matched healthy controls participated in the study. The subjects were
tested for maximum voluntary contractions (MVC), endurance and fatigue of the
thigh muscles on an isokinetic dynamometer (KinComs). Endurance was expressed
as the number of attained repetitions of knee extension and muscle fatigue as a
fatigue index (FI).
MVC in knee extension was 17% lower in female patients (P ¼ 0:017) but no
difference was found in male patients (P ¼ 0:56) compared to controls. MVC in knee
flexion was lower both in female (51%) (Po0:001) and male patients (40%) (Po0:001)
compared to controls. Both female and male patients had significantly lower muscle
endurance compared to controls. Female patients had a higher FI (22.5%) than
female controls (10%) (P ¼ 0:001) while no difference was found regarding FI
between male patients (15%) and male controls (10%) (P ¼ 0:103). The level of self-
reported everyday physical activity did not differ between groups.
The results showed impaired skeletal muscle function in COPD, except for MVC in
knee extension in male patients. Female patients seemed to be more prone to
decrease in thigh muscle function. More focus on improving muscle strength and
muscle endurance should be considered when designing pulmonary rehabilitation
programs. Patients with preserved level of physical activity can be included in
exercise programs and gender-related differences should be taken into account.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Exercise intolerance in patients with chronic
obstructive pulmonary disease (COPD) contributes
to a poor quality of life in these patients and an
increased need for medical assistance.1–3 This
exercise limitation has traditionally been explained
by the impairment of ventilatory function.4 How-
ever, studies have suggested that many patients
with COPD may stop exercising because of leg
muscle fatigue prior to ventilatory limitation.5,6
Furthermore, skeletal muscle dysfunction is com-
mon in patients with COPD and might be explained
by muscle atrophy, reduced oxidative metabolism,
reduced muscle capillarization and change in
muscle fiber type, i.e., reduced proportion of type
I fibers and increased proportion of type IIb.7,8
Inactivity is often assumed to be one of the main
reasons for these peripheral muscle abnormalities in
patients with COPD.9 Exercise training has been
shown to improve muscle function in patients with
COPD, suggesting that deconditioning is an important
contributor to the skeletal muscle dysfunction.10–13
Coronell et al.14 showed that despite relatively
preserved level of physical activity, patients with
COPD have reduced muscle function compared to
healthy age-matched controls, suggesting that other
factors than inactivity may contribute to the altera-
tions in peripheral muscle function. These factors,
related to the disease, are suggested to be mal-
nutrition, exposure to systemic corticosteroids,
tissue hypoxia, coexisting heart disease, systemic
inflammation, skeletal muscle apoptosis, oxidative
stress, tobacco use, individual susceptibility and
hormone alterations.4,8 In addition, some authors
have found elevated levels of inflammatory cyto-
kines indicating presence of systemic myopathy.15
The majority of the studies on lower-extremity
muscle function in COPD are focused on muscle
strength rather than muscle endurance. Further-
more, it is still unclear which modality of physical
training is the best to increase muscle function in
these patients. Defining whether patients with
COPD have reduced muscle strength and/or muscle
endurance compared to healthy controls is neces-
sary in order to be able to find the best exercise
modality for these patients. The level of everyday
physical activity is important to assess when
comparing skeletal muscle dysfunction in patients
with COPD with healthy controls. To our knowl-
edge, there are not many studies that have taken
this issue into consideration. Moreover, to the
authors’ knowledge, only Van0t Hul et al.16 have
investigated gender-related differences regarding
muscle strength and endurance of lower extremi-
ties in patients with COPD.Our hypothesis is that peripheral muscle abnorm-
alities found in patients with COPD might lead to
decrease in muscle strength and endurance which
consequently results in increased muscle fatigabil-
ity. The aim of this study was thus (i) to determine
whether patients with COPD have impaired
strength and endurance in the thigh muscles
compared to age-matched healthy controls, (ii) to
investigate if the level of self-reported everyday
physical activity was decreased in patients with
COPD and (iii) whether gender-related differences
in muscle performance exist compared to a control
group.Material and methods
Study population
Forty-two patients (26 women and 16 men) aged
53–74 years with moderate to severe, stable COPD
and 53 (29 women and 24 men) age-matched
healthy controls were included in the study. The
patients were clinically diagnosed with COPD
according to GOLD criteria17 and recruited from
outpatients on treatment at two Hospitals in
Northern Sweden. The inclusion criteria used to
select the patients were FEV1/VCo0.7, FEV1o80%
of predicted, stable medication and no infection
during the last month before participating in the
study, and absence of cardiac, orthopaedic, neuro-
logical or psychological disorders. All patients
performed an exercise electrocardiogram test on
a cycle ergometer (Rodby TM, RE 829, Enho¨rna,
Sweden) and a spirometry test (Spirolab, Medical
International Research, Roma, Italy) before enter-
ing the study. The patients were ex-smokers and
none of them were treated with long-term oxygen
therapy. Thirty-three patients were using inhaled
corticosteroids and one used daily oral corticoster-
oids. None of them was engaged in any organized
physical activity before the study. The patients
were referred to the clinic to participate in a
pulmonary rehabilitation program and were tested,
in addition to other tests, for muscle strength and
endurance. The healthy control group was re-
cruited from pensioner’s associations in Umea˚,
Sweden. The controls had to meet the following
criteria: age between 53 and 74 and no presence of
pulmonary, cardiac, orthopaedic, neurological or
psychological disorders. The controls should not
have smoked in the last 10 years and should not be
participants in any organized physical activity.
All subjects gave their informed consent before
the study. The Research Ethics Committee of
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dnr 99-067).
One patient was not included in the analyses
because he did not understand the instructions and
could not complete the protocol. One subject in
the control group dropped out because she ad-
mitted she had pain in the hips during the tests.
Two other control subjects were excluded from the
analyses of the endurance test because of technical
problems. Anthropometric data for patients with
COPD and controls are presented in Table 1.Isokinetic tests
The tests were performed using an isokinetic
dynamometer (KinComs, Chattanoga, IL) and the
dominant leg was evaluated. The test consisted of
two different parts: maximal contractions of the
thigh muscles and an endurance test. Standardized
verbal encouragement and instructions were
strictly applied for both groups. During the mea-
surements, the subjects were seated according to
the recommendation by the manufacturer. Before
the experiment the subjects performed a 5min
warm up on a cycle ergometer (Monark 818E,
ergomedic, Sweden) with a light load. In order to
become familiar with the test procedure the
subjects performed four knee extensions at an
angular velocity of 601/s on KinComs. The subjects
rested at least 2min before starting the test.
The isokinetic dynamometers are a valid and
reliable method for assessing strength and endur-
ance of the thigh muscles.18–20 The protocol used
for the tests has been found to be reliable and has
previously been used to evaluate muscle perfor-
mance in healthy young and elderly persons and
patients with ischemic stroke.21–23Table 1 Characteristics of the study population.
COPD patients (n ¼ 41)
Men (n ¼ 15) Women (n
Age (yr) 6676 6475
BMI (kg/m2) 2673 2875a
PA score 3.4770.8 3.3070.7
FEV1(l) 1.570.40 1.270.24
FEV1% pred. 50711.5 56711
VC (l) 3.770.9 2.670.6
VC% pred. 92715b 100721
FEV1/VC% 40712 4579.5
Data are presented as mean7SD. BMI ¼ body mass index; PA sco
aSignificantly different from female controls (P ¼ 0:004).
bSignificantly different from female COPD patients (P ¼ 0:029)Maximal voluntary contractions (MVC)
The subjects performed four repetitions of maximal
knee extension at 901/s. They were instructed to
extend the leg four times in a row with maximal
effort and to rest on the way back (flexion phase).
They rested at least 2min before performing the
maximal dynamic flexion.
Four repetitions of maximal knee flexion were
performed at 90o/s with a passive extension phase.
The subjects were instructed to flex the leg four
times in a row with maximal effort and to rest on
the way back (extension phase). The subjects
rested at least 5min before the endurance test.
The highest mean force value (Newton) of the
four repetitions obtained in the isokinetic device
for maximal contractions in extension and flexion
was chosen as the outcome measure.Endurance test
The endurance test consisted of maximally 100
maximal knee extensions at 90o/s. The subjects
were instructed to extend the leg as many times as
possible and the maximal effort in the extension
phase was required. They were supposed to
continue until the test leader asked them to stop
(when 100 repetitions were attained) or, if less than
100, until exhaustion. No rest was allowed between
the passive flexion phase and the active extension
phase. The 0–10 category ratio scale by Borg (CR10)
24 was used to rate perceived exertion of the thigh
muscles throughout the 100 maximal contractions.
The subjects rated their perceived exertion at
every fifth contraction until the 60th and, there-
after, at every tenth contraction until exhaustion or
at 100th repetition.Controls (n ¼ 52)
¼ 26) Men (n ¼ 24) Women (n ¼ 28)
6775 6476
2573 2572
3.6371 3.3670.7
re ¼ physical activity score
.
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of attained repetitions of knee extension. Muscle
fatigue was expressed as a fatigue index (FI) and
was analysed using the first 30 contractions of the
endurance test.
Level of self-reported physical activity
A questionnaire, validated to evaluate level of self-
reported physical activity in healthy elderly peo-
ple, was applied.25 It has also been used for
patients with COPD in a previous study.13 This
questionnaire concerns household activities, lei-
sure-time and sports activities during the previous
4 weeks. The level of self-reported physical activity
(PA score) was ranging from 1 to 6. Scores 1–2 were
classified as low level of physical activity, scores
3–4 were classified as medium level of physical
activity and scores 5–6 as high level of physical
activity.
Data acquisition and statistics
Based on previous studies, the mean force during
the endurance test shows a pattern with a steep
decrease during the first 30–50 contractions
(fatigue phase) and, after that, a stable level
(endurance level).22 The reason we decided to
evaluate fatigue only during the first 30 contrac-
tions was because all patients with COPD suc-
ceeded to attain at least this number of
contractions. For evaluation of fatigue we formed
a FI. This index was a slight modification of the
dimensionless index suggested by Merletti.26 To
form the FI, the intercept (m) from the regression
analysis of the initial 30 contractions of the
endurance test was calculated for each subject.
The intercept represents the intial value of the
endurance test. From m and the force values of
each individual, the FI was calculated as
FI ¼ 1
mN
XN
i¼1
ðm XiÞ,
where X is mean force value, i is the contraction
number, and N is the number of contractions.
Higher values for FI indicate increased muscle
fatigue. FI represents the relative loss in mean
force throughout the 30 first contractions and is
presented in percentage (%).
For statistical analysis the SPSS version 11.5 for
Windows was used. Tests of normality (Kolmogor-
ov–Smirnov and Shapiro–Wik) were used to check
whether the data were normally distributed or not.
In case of normal distribution, independent para-
metric sample t-test was used to compare the twogroups. When data were not normally distributed,
as for FI, or data on ordinal level, as CR-10, the
non-parametric Mann–Whitney U-test was used to
compare differences between groups. Power was
calculated when non-significant differences were
found. The results are presented as mean and
standard deviation (SD) and median, minimum and
maximum values for parametric and non-para-
metric tests, respectively.Results
Patients with COPD and healthy controls were well
matched for age and level of self-reported physical
activity. However, a significant difference was
found regarding body mass index (BMI) between
female patients with COPD and female controls.
MVC in knee extension was 17% lower (P ¼ 0:017)
in female patients but no difference was found in
male patients (P ¼ 0:56) compared with controls
(Table 2). The statistical power of this variable in
males was 9%. MVC in flexion was 51% lower in
female (Po0:001) and 40% lower in male (Po0:001)
patients compared with controls.
Muscle endurance was lower in patients with
COPD. All controls performed 100 repetitions in the
endurance test while only 27% of the female
patients and 53% of the male patients were able
to attain this number (Fig. 1). FI was found to be
higher in female patients with COPD (22.5%)
compared to female controls (10%) (P ¼ 0:001)
(Fig. 2b and Table 2). No significant difference
was found regarding FI between male patients
(15%) and male controls (10%) (P ¼ 0:103) (Fig. 2a
and Table 2). Both female patients and female
controls started the endurance test with approxi-
mately 80% of what they performed in the test of
maximal contractions in extension. Male controls
started the endurance test at their maximum force
in extension while male patients began the test at
approximately 80% of their maximal force in
extension (P ¼ 0:058). Female patients rated high-
er perceived exertion at the 30th contraction
compared to female controls (P ¼ 0:000) while
male patients and male controls rated approxi-
mately the same perceived exertion at the 30th
contraction (Table 2).Discussion
The major finding of this study was that thigh
muscle function is impaired in patients with COPD
both in muscle strength (except for extension in
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Figure 1 Percentage (%) of subjects succeeding different
numbers of repetitions in the endurance test for controls
and COPD (men and women).
Table 2 Maximal strength of the thigh muscles and fatigue during the 30 first contractions of the endurance
test.
Men Women
COPD Controls COPD Controls
Maximal strength in
extension (Newton)
274783 289770 225761a 272777
Maximal strength in
flexion (Newton)
121751b 203746 87734c 179747
Intercept (Newton) 243 (51–349) 271 (177–446) 198 (89–337) 230 (96–380)
Fatigue index (FI%) 15 (222–27) 10 (90–25) 22.5 (39–33)c 10 (54–25)
Borg ratings at 30th
contraction
4 (2–10) 4 (0–9) 6 (2–10)c 3 (0–10)
Data are presented as mean7SD for maximal strength and as median (minimum-maximum) for intercept, FI and Borg.
aSignificantly different from female controls (Po0:05).
bSignificantly different from male controls (Po0:001).
cSignificantly different from female controls (Po0:001).
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Figure 2 Pattern of force loss during the endurance test
for men (a) and women (b) in controls and patients with
COPD. All controls performed 100 repetitions and all
patients performed 30 repetitions. Some patients
dropped out successively during the test. The remaining
number of patients is illustrated at every 10th contrac-
tion. The dashed line shows the area for calculation of
the fatigue index (FI). *Significantly higher FI for women
with COPD (P ¼ 0:01).
Thigh muscle strength and endurance in patients with COPD compared with healthy controls 1455male patients) and muscle endurance compared to
age-matched healthy controls. However, the level
of self-reported everyday physical activity did not
differ between groups. We also found gender-
related differences in patients with COPD regarding
skeletal muscle dysfunction where women seem
to be more prone to decrease in thigh muscle
function. There was a significant difference in BMI
between female patients and female controls, but
this difference (25–28) is probably not of clinical
relevance that it could explain the results.
Maximal strength of the thigh muscles was found
to be impaired in our group of patients with
COPD which agrees with results of previous stu-
dies.14,16,27,28 This muscle weakness may be related
to the reduced muscle cross-sectional area (muscle
atrophy) previously reported in patients with
COPD.8,29 Interestingly, we did not find any weak-
ness of the thigh muscles in extension in male
patients compared to male controls. The reason forthis relatively preserved maximal strength in
extension of male patients compared to controls
is not clear. The small sample of men with COPD
might have contributed to this finding. Because of
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extension in males) was 9%, we cannot affirm that
this non-significant result really exists.
We found that muscle endurance was impaired
both in female and male patients compared
to controls. This finding is in accordance with
results of previous studies.9,14,16,30,31. Also, female
patients were found to have greater degree of
fatigue (FI) during the first 30 contractions of the
endurance test compared to female controls, but
this was not the case in male patients. Our results
differ from findings by Zattara-Hartman et al.32
who did not find any reduction in endurance of
vastus lateralis in patients with COPD compared to
controls. Staron et al.33 studied muscle fiber-type
composition of the vastus lateralis in healthy young
men and women and showed that the percentage
area of the fast oxidative type IIa fibers were the
largest for men, whereas the percentage area of
the slow oxidative type I fibers were the largest for
women. This may explain why we did not find any
difference in degree of fatigue (FI) during the first
30 contractions in male patients compared to male
controls. Male subjects might preferentially use a
greater proportion of type IIa fibers and may,
therefore, not be affected to a great extent by a
reduced proportion of type I fibers that is present in
chronic obstructive pulmonary disease. Another
reason might be that the subjects worked at
different intensities of their maximal force in
extension during the endurance test, a difference
that possibly could have accounted for the ob-
served difference. Male controls started the en-
durance test at their maximal force in extension
whereas male patients began the test at approxi-
mately 80% of their maximal force in extension.
Although this difference was not significant
(P ¼ 0:058), it might have contributed to a greater
fatigue of the control subjects during the 30 first
contractions. However, despite the fact that we did
not find any difference in FI between male patients
and male controls, the patients did not manage to
attain 100 repetitions which indicates impaired
endurance of the thigh muscles.
In our study, the questionnaire used to evaluate
PA score between the two groups has been shown to
be a good instrument because it was developed for
elderly people and the alternatives were not only
about sport and leisure-time activities but also
about household activities.25 Although some sub-
jects in our study cannot be considered elderly, the
average age of the groups was approximately 65
years old. In the present study, the questionnaire
showed that the patients and the controls had the
same score of level of self-reported physical
activity and thus no indication of a more sedentarylifestyle was found. In the patient group our results
showed impaired strength and endurance of the
thigh muscles despite their relatively preserved
level of physical activity. Coronell et al.,14 using
another questionnaire, also indicated that dysfunc-
tion in strength and endurance of quadriceps can
be found in patients with relatively normal level of
physical activity. This finding suggests that other
factors than inactivity may contribute to the
alterations in peripheral muscle function in pa-
tients with COPD. However, the PA questionnaire
might be sensitive to determine differences regard-
ing what the patients perform, e.g. type, fre-
quency and duration of physical activity but not
regarding how they perform the activity, e.g. which
intensity. A recent study34 has showed that patients
with COPD walk with lower movement intensity
compared to healthy controls. Despite the pre-
served level of self-reported physical activity, we
believe that these patients might experience the
exercise as more demanding than healthy controls.
Furthermore, female patients had greater degree
of fatigue and rated higher perceived exertion at
the 30th contraction than female controls. Besides,
the main reported reason for the patients with
COPD to stop the endurance test before completing
100 repetitions was perceived fatigue and discom-
fort in the leg and not dyspnoea.
In this study, peripheral muscle dysfunction was
found in patients with COPD. Female patients
seemed to be more prone to decrease in thigh
muscle function. These findings are of clinical
importance since muscle weakness is associated
with exercise intolerance, poor quality of life and
an increased need for medical assistance1–3. Based
on our findings, pulmonary rehabilitation should be
more focused on improving skeletal muscle func-
tion. Both muscle strength and muscle endurance
training should be included in the exercise training
programs. In accordance with our results, two
recent reviews10,35 showed that muscle strength
training should be part of the pulmonary rehabilita-
tion. Endurance training has also been shown to be
of benefit for patients with COPD.35 Currently,
endurance training programs used for patients with
COPD consist mainly of walking and cycling ex-
ercises that improve the cardio-respiratory system.
However, to improve muscular endurance, specific
muscle endurance trainings with many repetitions
and low loads are required. Not only sedentary
patients with COPD but also non-sedentary patients
should be considered for physical training. More-
over, since we found gender-related differences of
muscle performance, this issue also needs to be
considered when designing rehabilitation programs
for these patients.
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